Active Filter(s):
Details:
The net proceeds will support development of a foundational machine learning model of medicinal chemistry that can accurately predict small molecule drug candidates for any protein.
Lead Product(s): Undisclosed
Therapeutic Area: Technology Product Name: Undisclosed
Highest Development Status: Discovery Platform Product Type: Small molecule
Partner/Sponsor/Collaborator: Springtide Ventures
Deal Size: $9.3 million Upfront Cash: Undisclosed
Deal Type: Financing April 05, 2024